Literature DB >> 2182100

Epidermolytic hyperkeratosis: generalized form in children from parents with systematized linear form.

V Nazzaro1, E Ermacora, B Santucci, R Caputo.   

Abstract

Two unrelated families are presented in both of which a child with generalized epidermolytic hyperkeratosis (congenital bullous ichthyosiform erythroderma) had a parent with linear epidermolytic hyperkeratosis (epidermolytic epidermal naevus). Light and electron microscopy of skin biopsies of lesions from the children and parents showed typical epidermolytic hyperkeratosis. Gonadal mosaicism in patients with linear epidermolytic hyperkeratosis may be responsible for transmission of the abnormality to the offspring.

Entities:  

Mesh:

Year:  1990        PMID: 2182100     DOI: 10.1111/j.1365-2133.1990.tb08292.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

Review 1.  Neonatal erythroderma: differential diagnosis and management of the "red baby".

Authors:  P H Hoeger; J I Harper
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

2.  Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel genetic concept.

Authors:  Pamela Poblete-Gutiérrez; Tonio Wiederholt; Arne König; Frank K Jugert; Yvonne Marquardt; Albert Rübben; Hans F Merk; Rudolf Happle; Jorge Frank
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

3.  Epidermolytic Nevus: An Instance of Mosaic Epidermolytic Ichthyosis.

Authors:  Keshavmurthy A Adya; Arun C Inamadar; Ajit B Janagond; Aparna Palit
Journal:  Indian Dermatol Online J       Date:  2020-03-09

4.  First Case of KRT2 Epidermolytic Nevus and Novel Clinical and Genetic Findings in 26 Italian Patients with Keratinopathic Ichthyoses.

Authors:  Andrea Diociaiuti; Daniele Castiglia; Marialuisa Corbeddu; Roberta Rotunno; Sabrina Rossi; Elisa Pisaneschi; Claudia Cesario; Angelo Giuseppe Condorelli; Giovanna Zambruno; May El Hachem
Journal:  Int J Mol Sci       Date:  2020-10-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.